EICHORCondition: Glioblastoma · Sponsor: NovoCure Ltd.
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This prospective multicenter non-interventional study (NIS) aims at confirming the survival benefit of Optune Gio® - in terms of OS and PFS - and describing device usage (compliance will be measured through patient's usage report, recorded by each device) and impact on QoL, in a real-life setting in France, in a large cohort of participants with newly diagnosed GBM who completed radiotherapy and concomitant TMZ after surgery and initiatingtreatment with Optune Gio® device together with maintenance TMZ. A special emphasis will be given to the evaluation of QoL and the impact of Optune Gio® on daily life, considering the limited life expectancy of these patients, the symptom burden and significant disease-related disability.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Chu Amiens Picardie | Amiens, France | Recruiting |
| Institut Sainte-Catherine | Avignon, France | Recruiting |
| Chu Saint Andre | Bordeaux, France | Recruiting |
| Chu Brest Hopital Morvan | Brest, France | Recruiting |
| Hopital Neurologie Pierre Wetrheimer | Bron, France | Recruiting |
| Crlcc Francois Baclesse | Caen, France | Recruiting |
| Centre Lutte Contre Le Cancer Jean Perrin | Clermont-Ferrand, France | Recruiting |
| Crlcc Georges Francois Leclerc | Dijon, France | Recruiting |
| Chu de Grenoble Alpes | La Tronche, France | Recruiting |
| Hopital Roger Salengro | Lille, France | Recruiting |
| Centre Hospitalier La Timone | Marseille, France | Recruiting |
| Institut du Cancer de Montpellier - Val d'Aurelle | Montpellier, France | Recruiting |
+ 12 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06924099